NEWTON, MA, Privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round. Read More
NEW YORK, NY, SOLS, the pioneer in 3D printing and custom mass manufacturing, today announced the completion of an $11.1 million Series B funding round. Read More
SEATTLE, WA, Most complete backend platform built exclusively for live games, announced today it has raised $7.4 million in a Series A funding. Read More